Annuncio pubblicitario
Italia markets open in 8 hours 9 minutes
  • Dow Jones

    38.852,27
    +176,59 (+0,46%)
     
  • Nasdaq

    16.349,25
    +192,92 (+1,19%)
     
  • Nikkei 225

    38.236,07
    -38,03 (-0,10%)
     
  • EUR/USD

    1,0771
    +0,0005 (+0,04%)
     
  • Bitcoin EUR

    58.946,50
    -308,98 (-0,52%)
     
  • CMC Crypto 200

    1.367,84
    +55,22 (+4,21%)
     
  • HANG SENG

    18.578,30
    +102,38 (+0,55%)
     
  • S&P 500

    5.180,74
    +52,95 (+1,03%)
     

Correction - Autolus Therapeutics to report third quarter 2023 financial results and host conference call on November 2, 2023

Autolus Therapeutics plc
Autolus Therapeutics plc

LONDON, Oct. 11, 2023 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (Nasdaq: AUTL), a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, today announced that it will release its third quarter 2023 financial results and operational highlights before open of US markets on Thursday, November 2, 2023.

Management will host a conference call and webcast at 9:00 am ET/1:00 pm GMT to discuss the company’s financial results and provide a general business update. Conference call participants should pre-register using this link to receive the dial-in numbers and a personal PIN, which are required to access the conference call.

A simultaneous audio webcast and replay will be accessible on the events section of Autolus’ website.

ANNUNCIO PUBBLICITARIO

Contact:

Julia Wilson
+44 (0) 7818 430877
j.wilson@autolus.com

Susan A. Noonan
S.A. Noonan Communications
+1-917-513-5303
susan@sanoonan.com

Lauren Williams
Investase
+44 23 9438 7760
lauren@investase.com